Prognostic Significance of SOX2 Expression in Nasopharyngeal Carcinoma (Q83210608)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22236193 AND SRC:MED&resulttype=core&format=json

20 January 2020

title

Prognostic significance of SOX2 expression in nasopharyngeal carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22236193 AND SRC:MED&resulttype=core&format=json

20 January 2020

Prognostic Significance of SOX2 Expression in Nasopharyngeal Carcinoma (English)

1 reference

https://api.crossref.org/works/10.3109/07357907.2011.630049

22 December 2024

author name string

Xin Wang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22236193 AND SRC:MED&resulttype=core&format=json

20 January 2020

Yi Liang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22236193 AND SRC:MED&resulttype=core&format=json

20 January 2020

Qiong Chen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22236193 AND SRC:MED&resulttype=core&format=json

20 January 2020

Hui-Min Xu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22236193 AND SRC:MED&resulttype=core&format=json

20 January 2020

Nan Ge

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22236193 AND SRC:MED&resulttype=core&format=json

20 January 2020

Rong-Zhen Luo

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22236193 AND SRC:MED&resulttype=core&format=json

20 January 2020

Jian-Yong Shao

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22236193 AND SRC:MED&resulttype=core&format=json

20 January 2020

Zhiwei He

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22236193 AND SRC:MED&resulttype=core&format=json

20 January 2020

Yi-Xin Zeng

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22236193 AND SRC:MED&resulttype=core&format=json

20 January 2020

Tiebang Kang

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22236193 AND SRC:MED&resulttype=core&format=json

20 January 2020

Jing-Ping Yun

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22236193 AND SRC:MED&resulttype=core&format=json

20 January 2020

Fangyun Xie

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22236193 AND SRC:MED&resulttype=core&format=json

20 January 2020

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=22236193

22 December 2024

publication date

1 January 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22236193 AND SRC:MED&resulttype=core&format=json

20 January 2020

January 2012

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=22236193

full work available at URL

22 December 2024

number of pages

7

1 reference

based on heuristic

inferred from page(s)

http://www.tandfonline.com/doi/pdf/10.3109/07357907.2011.630049

1 reference

https://api.crossref.org/works/10.3109/07357907.2011.630049

22 December 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22236193 AND SRC:MED&resulttype=core&format=json

20 January 2020

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22236193 AND SRC:MED&resulttype=core&format=json

20 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22236193 AND SRC:MED&resulttype=core&format=json

20 January 2020

page(s)

79-85

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22236193 AND SRC:MED&resulttype=core&format=json

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

20 January 2020

cites work

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1016/J.CELL.2007.11.019

Core transcriptional regulatory circuitry in human embryonic stem cells

1

1 reference

https://api.crossref.org/works/10.3109/07357907.2011.630049

Dissecting self-renewal in stem cells with RNA interference

22 December 2024

2

1 reference

https://api.crossref.org/works/10.3109/07357907.2011.630049

Sox2 roles in neural stem cells

22 December 2024

3

1 reference

https://api.crossref.org/works/10.3109/07357907.2011.630049

Sox2 is important for two crucial processes in lung development: branching morphogenesis and epithelial cell differentiation

22 December 2024

4

1 reference

https://api.crossref.org/works/10.3109/07357907.2011.630049

Mutations in SOX2 cause anophthalmia-esophageal-genital (AEG) syndrome

22 December 2024

5

1 reference

https://api.crossref.org/works/10.3109/07357907.2011.630049

In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state

22 December 2024

7

1 reference

https://api.crossref.org/works/10.3109/07357907.2011.630049

Correlation of CD133, OCT4, and SOX2 in rectal cancer and their association with distant recurrence after chemoradiotherapy

22 December 2024

8

1 reference

https://api.crossref.org/works/10.3109/07357907.2011.630049

Histopathologic evaluation of stepwise progression of pancreatic carcinoma with immunohistochemical analysis of gastric epithelial transcription factor SOX2: comparison of expression patterns between invasive components and cancerous or nonneoplasti

22 December 2024

10

1 reference

https://api.crossref.org/works/10.3109/07357907.2011.630049

Oncogenic pathway signatures in human cancers as a guide to targeted therapies

22 December 2024

11

1 reference

https://api.crossref.org/works/10.3109/07357907.2011.630049

Sox2: a possible driver of the basal-like phenotype in sporadic breast cancer

22 December 2024

12

1 reference

https://api.crossref.org/works/10.3109/07357907.2011.630049

22 December 2024

Nasopharyngeal carcinoma

14

1 reference

https://api.crossref.org/works/10.3109/07357907.2011.630049

Intensity-modulated radiotherapy for early-stage nasopharyngeal carcinoma: a prospective study on disease control and preservation of salivary function

22 December 2024

16

1 reference

https://api.crossref.org/works/10.3109/07357907.2011.630049

Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: The Hong Kong experience

22 December 2024

17

1 reference

https://api.crossref.org/works/10.3109/07357907.2011.630049

Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience.

22 December 2024

18

1 reference

https://api.crossref.org/works/10.3109/07357907.2011.630049

Lung metastasis alone in nasopharyngeal carcinoma: A relatively favorable prognostic group

22 December 2024

19

1 reference

https://api.crossref.org/works/10.3109/07357907.2011.630049

22 December 2024

20

16

113

Liu MT

1998

1 reference

https://api.crossref.org/works/10.3109/07357907.2011.630049

Comparison of the prognostic impact of serum anti-EBV antibody and plasma EBV DNA assays in nasopharyngeal carcinoma

22 December 2024

21

1 reference

https://api.crossref.org/works/10.3109/07357907.2011.630049

TNM Classification of Malignant Tumors, fifth edition (1997). Union Internationale Contre le Cancer and the American Joint Committee on Cancer

22 December 2024

22

1 reference

https://api.crossref.org/works/10.3109/07357907.2011.630049

Stem cells, cancer, and cancer stem cells

22 December 2024

23

1 reference

https://api.crossref.org/works/10.3109/07357907.2011.630049

Efficient tumour formation by single human melanoma cells

22 December 2024

24

1 reference

https://api.crossref.org/works/10.3109/07357907.2011.630049

Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience

22 December 2024

25

1 reference

https://api.crossref.org/works/10.3109/07357907.2011.630049

SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas

22 December 2024

26

1 reference

https://api.crossref.org/works/10.3109/07357907.2011.630049

The molecular mechanism governing the oncogenic potential of SOX2 in breast cancer

22 December 2024

27

1 reference

https://api.crossref.org/works/10.3109/07357907.2011.630049

SOX2 silencing in glioblastoma tumor-initiating cells causes stop of proliferation and loss of tumorigenicity.

22 December 2024

28

1 reference

https://api.crossref.org/works/10.3109/07357907.2011.630049

SOX2 is frequently downregulated in gastric cancers and inhibits cell growth through cell-cycle arrest and apoptosis

22 December 2024

29

1 reference

https://api.crossref.org/works/10.3109/07357907.2011.630049

Embryonic stem cell markers expression in cancers.

22 December 2024

30

1 reference

https://api.crossref.org/works/10.3109/07357907.2011.630049

Gene expression changes in an animal melanoma model correlate with aggressiveness of human melanoma metastases

22 December 2024

31

1 reference

https://api.crossref.org/works/10.3109/07357907.2011.630049

22 December 2024

32

28

57

Ling W

2009

1 reference

https://api.crossref.org/works/10.3109/07357907.2011.630049

22 December 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22236193 AND SRC:MED&resulttype=core&format=json

20 January 2020

1 reference